APA (7th ed.) Citation

Luo, P., Zhang, Z., Zhang, L., Zhang, P., Zhang, M., Liu, J., & Zhou, Z. (2025). Mitochondrial Pathway Signature (MitoPS) predicts immunotherapy response and reveals NDUFB10 as a key immune regulator in lung adenocarcinoma. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Luo, Peng, Zhenfa Zhang, Lianmin Zhang, Pengpeng Zhang, Mengzhe Zhang, Jianlan Liu, and Zhaokai Zhou. Mitochondrial Pathway Signature (MitoPS) Predicts Immunotherapy Response and Reveals NDUFB10 as a Key Immune Regulator in Lung Adenocarcinoma. BMJ Publishing Group, 2025.

MLA (9th ed.) Citation

Luo, Peng, et al. Mitochondrial Pathway Signature (MitoPS) Predicts Immunotherapy Response and Reveals NDUFB10 as a Key Immune Regulator in Lung Adenocarcinoma. BMJ Publishing Group, 2025.